Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 12,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 10 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,178 F15 · kind: Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron LLC. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 21,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 9 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,387 F14 · kind: Maveron LLC distributed for no consideration 21,566 shares of common stock of the issuer to its members on August 7, 2020. F12 · ownership.nature: Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 219 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 8 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 26,953 F13 · kind: Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron Associates. F12 · ownership.nature: Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 21,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 7 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 26,734 F11 · kind: Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron GP. F12 · ownership.nature: Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 114,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 6 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,844 F9 · kind: Maveron GP distributed for no consideration 114,393 shares of common stock of the issuer to its members on August 7, 2020. F10 · ownership.nature: Shares owned directly by Maveron GP. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 2,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 5 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 117,237 F8 · kind: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. F8 · ownership.nature: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 13,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 4 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,000 F6 · kind: Maveron III Entrepreneurs Fund, L.P. ("Maveron Entrepreneurs") made pro rata distributions for no consideration of 13,114 shares of common stock of the issuer to its partners on August 7, 2020. F7 · ownership.nature: Shares owned directly by Maveron Entrepreneurs. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Entrepreneurs, and may be deemed to share voting and investment power over the securities held by Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 58,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 3 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F4 · kind: MEP Associates III, L.P. ("Maveron Associates") made pro rata distributions for no consideration of 58,538 shares of common stock of the issuer to its partners on August 7, 2020. F5 · ownership.nature: Shares owned directly by Maveron Associates. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Associates, and may be deemed to share voting and investment power over the securities held by Maveron Associates. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 88,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 2 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 114,509 F3 · kind: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. F3 · ownership.nature: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:21 UTC |
Levitan DanDirector
|
OtherCommon Stock | 426,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-093440 · tm2027240-1_4.xml · nonDerivative · entry 1 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Maveron Equity Partners III, L.P. ("Maveron Equity") made pro rata distributions for no consideration of 426,934 shares of common stock of the issuer to its partners on August 7, 2020. F2 · ownership.nature: Shares owned directly by Maveron Equity. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron General Partner III LLC ("Maveron GP"), which is the general partner of Maveron Equity, and may be deemed to share voting and investment power over the securities held by Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:34 UTC |
Friedman GavinChief People Officer
|
SaleCommon Stock | 1,400 | $68.31 | $95,635.82 |
DisclosureSEC source: 0001371285-20-000190 · wf-form4_159718166234574.xml · nonDerivative · entry 1 Friedman Gavin · CIK 0001800776 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.30 to $68.35 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,688 | $0.00 Strike: $16.06 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · derivative · entry 28 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,688 shares Expires 2024-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F33 · derivative.exercise_date: This stock option grant is fully vested. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,482 | $0.00 Strike: $8.57 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · derivative · entry 27 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,482 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F33 · derivative.exercise_date: This stock option grant is fully vested. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 12,688 | $69.71 | $884,469.06 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 26 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,258 F32 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.34 to $70.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
Exercise / conversionCommon Stock | 12,688 | $16.06 | $203,769.28 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 25 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 20,482 | $69.71 | $1,427,781.79 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 24 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,258 F32 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.34 to $70.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
Exercise / conversionCommon Stock | 20,482 | $8.57 | $175,530.74 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 23 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 20,950 | $70.04 | $1,467,367.33 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 22 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust - Levitan Family Foundation Disclosed balance after: 0 F30 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.93 to $70.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F31 · ownership.nature: Shares are held by a trust the holdings of which are attributable to the reporting person. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 552 | $69.85 | $38,555.65 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 21 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,835 F28 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.82 to $69.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F29 · ownership.nature: Shares owned directly by Maveron LLC. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 73 | $71.53 | $5,221.68 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 20 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F27 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.49 to $71.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F25 · ownership.nature: Shares owned directly by Maveron GP. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 1,163 | $70.69 | $82,215.49 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 19 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 73 F26 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.48 to $71.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F25 · ownership.nature: Shares owned directly by Maveron GP. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 1,608 | $70.10 | $112,723.21 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 18 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,236 F24 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.48 to $70.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F25 · ownership.nature: Shares owned directly by Maveron GP. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 127 | $71.53 | $9,084.28 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 17 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F23 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.49 to $71.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F21 · ownership.nature: Shares owned directly by Maveron Entrepreneurs. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 2,046 | $70.69 | $144,637.06 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 16 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 127 F22 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.48 to $71.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F21 · ownership.nature: Shares owned directly by Maveron Entrepreneurs. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 2,827 | $70.10 | $198,176.94 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 15 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,173 F20 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.48 to $70.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F21 · ownership.nature: Shares owned directly by Maveron Entrepreneurs. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 7,173 | $69.63 | $499,484.68 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 14 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,258 F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.34 to $69.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
SaleCommon Stock | 25,000 | $70.01 | $1,750,305.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 13 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,431 F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 34,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 12 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,431 F17 · kind: Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron GP. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 9,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 11 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,436 F16 · kind: Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron Associates. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 12,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 10 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,178 F15 · kind: Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron LLC. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 21,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 9 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,387 F14 · kind: Maveron LLC distributed for no consideration 21,566 shares of common stock of the issuer to its members on August 7, 2020. F12 · ownership.nature: Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 219 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 8 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 26,953 F13 · kind: Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron Associates. F12 · ownership.nature: Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 21,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 7 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 26,734 F11 · kind: Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron GP. F12 · ownership.nature: Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 114,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 6 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,844 F9 · kind: Maveron GP distributed for no consideration 114,393 shares of common stock of the issuer to its members on August 7, 2020. F10 · ownership.nature: Shares owned directly by Maveron GP. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 2,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 5 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 117,237 F8 · kind: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. F8 · ownership.nature: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 13,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 4 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,000 F6 · kind: Maveron III Entrepreneurs Fund, L.P. ("Maveron Entrepreneurs") made pro rata distributions for no consideration of 13,114 shares of common stock of the issuer to its partners on August 7, 2020. F7 · ownership.nature: Shares owned directly by Maveron Entrepreneurs. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Entrepreneurs, and may be deemed to share voting and investment power over the securities held by Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 58,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 3 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F4 · kind: MEP Associates III, L.P. ("Maveron Associates") made pro rata distributions for no consideration of 58,538 shares of common stock of the issuer to its partners on August 7, 2020. F5 · ownership.nature: Shares owned directly by Maveron Associates. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Associates, and may be deemed to share voting and investment power over the securities held by Maveron Associates. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 88,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 2 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 114,509 F3 · kind: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. F3 · ownership.nature: Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 07, 2020 Filed Oct 21, 2020 19:58 UTC Amendment |
Levitan DanDirector
|
OtherCommon Stock | 426,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116865 · tm2034039-1_4a.xml · nonDerivative · entry 1 LEVITAN DAN · CIK 0001202435 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Maveron Equity Partners III, L.P. ("Maveron Equity") made pro rata distributions for no consideration of 426,934 shares of common stock of the issuer to its partners on August 7, 2020. F2 · ownership.nature: Shares owned directly by Maveron Equity. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron General Partner III LLC ("Maveron GP"), which is the general partner of Maveron Equity, and may be deemed to share voting and investment power over the securities held by Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 06, 2020 Filed Feb 16, 2021 22:39 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
GiftCommon Stock | 39,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001371285-21-000043 · wf-form5_161351512936609.xml · nonDerivative · entry 2 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Kuyashii Primary Equities LLC Disclosed balance after: 937,222 F1 · kind: Represents transfer of shares from reporting person to Kuyashii Primary Equities, LLC, a limited liability company, indirectly, wholly-owned by the reporting person and reporting person's spouse. Read SEC document |
| August 06, 2020 Filed Feb 16, 2021 22:39 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
GiftCommon Stock | 39,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001371285-21-000043 · wf-form5_161351512936609.xml · nonDerivative · entry 1 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,585 F1 · kind: Represents transfer of shares from reporting person to Kuyashii Primary Equities, LLC, a limited liability company, indirectly, wholly-owned by the reporting person and reporting person's spouse. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 16:36 UTC |
LOW MURRAY BDirector
|
SaleCommon Stock | 2,000 | $50.22 | $100,440.00 |
DisclosureSEC source: 0001371285-20-000185 · wf-form4_159665975782027.xml · nonDerivative · entry 1 LOW MURRAY B · CIK 0001231933 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,501 F1 · kind: The sale reported is effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 18, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 22:57 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
SaleCommon Stock | 4,000 | $50.91 | $203,640.00 |
DisclosureSEC source: 0001371285-20-000175 · wf-form4_159589064632829.xml · nonDerivative · entry 1 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Kuyashii Primary Equities LLC Disclosed balance after: 934,222 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by Kuyashii Primary Equities LLC. a limited liability company indirectly, wholly-owned by the reporting person and reporting person's spouse, on November 12, 2019, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:38 UTC |
Friedman GavinChief People Officer
|
SaleCommon Stock | 300 | $49.52 | $14,856.00 |
DisclosureSEC source: 0001371285-20-000173 · wf-form4_159545749874405.xml · nonDerivative · entry 1 Friedman Gavin · CIK 0001800776 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,011 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 18, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 17:36 UTC |
PLOUF TRICIAChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $8.74 | $0.00 |
DisclosureSEC source: 0001371285-20-000171 · wf-form4_159502175299060.xml · derivative · entry 3 PLOUF TRICIA · CIK 0001673762 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 17,000 shares Expires 2024-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 27, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. F3 · derivative.exercise_date: This stock option grant is fully vested. Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 17:36 UTC |
PLOUF TRICIAChief Financial Officer
|
SaleCommon Stock | 17,000 | $48.56 | $825,457.10 |
DisclosureSEC source: 0001371285-20-000171 · wf-form4_159502175299060.xml · nonDerivative · entry 2 PLOUF TRICIA · CIK 0001673762 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,972 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 27, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.58 to $49.01 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 17:36 UTC |
PLOUF TRICIAChief Financial Officer
|
Exercise / conversionCommon Stock | 17,000 | $8.74 | $148,580.00 |
DisclosureSEC source: 0001371285-20-000171 · wf-form4_159502175299060.xml · nonDerivative · entry 1 PLOUF TRICIA · CIK 0001673762 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 27, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 21:35 UTC |
Tooth MargaretChief Revenue Officer
|
SaleCommon Stock | 500 | $47.45 | $23,725.00 |
DisclosureSEC source: 0001371285-20-000170 · wf-form4_159502173294527.xml · nonDerivative · entry 1 Tooth Margaret · CIK 0001657025 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,026 F1 · kind: The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 19, 2020, as amended on May 14, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 21:35 UTC |
BEARMAN ASHERChief Strategy Officer
|
SaleCommon Stock | 500 | $47.45 | $23,725.00 |
DisclosureSEC source: 0001371285-20-000169 · wf-form4_159502171594860.xml · nonDerivative · entry 1 BEARMAN ASHER · CIK 0001622728 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 F1 · kind: The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 6, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. Read SEC document |
| July 08, 2020 Filed Jul 10, 2020 20:36 UTC |
RAWLINGS DARRYLDirector · President and CEO
|
SaleCommon Stock | 4,000 | $45.18 | $180,722.40 |
DisclosureSEC source: 0001371285-20-000163 · wf-form4_159441338643357.xml · nonDerivative · entry 1 RAWLINGS DARRYL · CIK 0001611679 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Kuyashii Primary Equities LLC Disclosed balance after: 938,222 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by Kuyashii Primary Equities LLC. a limited liability company indirectly, wholly-owned by the reporting person and reporting person's spouse, on November 12, 2019, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.23 to $45.845 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.